PEX7 and Hodgkins lymphoma: A stop-gain variant NM_000288.4:c.875T>A (rs1805137) in PEX7, which is indicated in Clinvar as pathogenic, was observed in two cases from different families; one case had nodular sclerosis at age 30, while the other had Burkitt lymphoma at age 9.